Exchange: NASDAQ·Updated 07:30 PM EST

PAYS News

News
all
press releases
Paysign (NASDAQ:PAYS) Stock: Insider Joan Herman Sells 30,000 Shares
Paysign, Inc. (NASDAQ:PAYS - Get Free Report) EVP Joan Herman sold 30,000 shares of the company's stock in a transaction on Monday, November 16th. The stock was sold at an average price of $9.30, for a total value of $279,000.00. Following the sale, the executive vice president owned 579,421 shares...
MarketBeat
Paysign (NASDAQ:PAYS) Stock: Insider Joan Herman Sells 30,000 Shares
Paysign, Inc. (NASDAQ:PAYS - Get Free Report) EVP Joan Herman sold 30,000 shares of the company's stock in a transaction on Monday, November 16th. The stock was sold at an average price of $9.30, for a total value of $279,000.00. Following the sale, the executive vice president owned 579,421 shares...
MarketBeat
More News
Key PointsPharma patient affordability revenue grew 110% year-over-year to $16.6 million...
Nasdaq News: Markets
Paysign (PAYS) possesses solid growth attributes, which could help it handily outperform the market.
Zacks
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks
Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2026. Third Quarter 2026...
Business Wire
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss third quarter 2026 earnings at 5:00 p.m. Eastern time on Monday...
Business Wire
Here is how CBIZ (CBZ) and Paysign, Inc. (PAYS) have performed compared to their sector so far this year.
Zacks
Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks

Advertisement|Remove ads.